A study of long-term care facilities found residents with penicillin allergies were 95% less likely to receive beta-lactam antibiotics.

Results from the REVISIT trial show aztreonam-avibactam had similar cure rates as meropenem in patients with serious ...

The US Food and Drug Administration granted marketing clearances for multiple infectious disease tests and a blood culture sample preparation system, among other devices.

Aboriginal children living in remote communities have the highest rate of skin sores, or impetigo, in the world. Almost one ...

Babesiosis, a tick-borne disease similar to malaria, is increasing across the U.S., with a significant number of patients ...

Faster and more accurate diagnoses lead to more targeted and effective treatment plans, potentially reducing unnecessary antibiotic use and improving patient outcomes. The ability to rapidly identify ...

A change in policy may be helping to drive a rise in treatment-resistant vaginal thrush, amid  significant yearly increases in the prevalence of fungal infections caused by fungal Candida species, ...

Rates of babesiosis, a tick-borne parasitic disease, increased an average of 9% per year in the United States between 2015 and 2022 and four in 10 patients were found to be co-infected with another ...

The U.S. Food and Drug Administration has approved Elanco Animal Health's oral drug to protect dogs against six parasitic ...

The 25 projects are the first implementation awards under the multiyear Health Systems Implementation Initiative, which PCORI ...

Since the 1940s when antibiotics revolutionized medicine, they have enabled the effective treatment of bacterial infections ...

The newest drugs and treatments for rheumatoid arthritis (RA) include Janus kinase (JAK) inhibitors, a Bruton’s tyrosine kinase (BTK) inhibitor, and neurostimulation, among other treatments.